Exchange Traded Concepts
VCYT icon

Exchange Traded Concepts’s Veracyte VCYT Stock Holding History

Exchange Traded Concepts’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.19M Buy
177,873
+33,608
+23% +$1.62M 0.03% 405
2026
Q2 		$8.47M Sell
144,265
-1,660
-1% -$69.6K 0.04% 381
2026
Q1 		$4.7M Buy
145,925
+34,981
+32% +$1.29M 0.03% 415
2025
Q4 		$4.67M Sell
110,944
-21,490
-16% -$866K 0.04% 423
2025
Q3 		$4.55M Buy
132,434
+17,393
+15% +$499K 0.04% 417
2025
Q2 		$3.11M Buy
115,041
+23,047
+25% +$668K 0.04% 409
2025
Q1 		$2.73M Buy
91,994
+22,565
+33% +$860K 0.05% 317
2024
Q4 		$2.75M Sell
69,429
-21,414
-24% -$811K 0.05% 305
2024
Q3 		$3.09M Sell
90,843
-41,458
-31% -$1.17M 0.07% 232
2024
Q2 		$2.87M Sell
132,301
-12,106
-8% -$255K 0.07% 226
2024
Q1 		$3.2M Buy
144,407
+50,506
+54% +$1.23M 0.08% 219
2023
Q4 		$2.58M Buy
93,901
+13,482
+17% +$325K 0.07% 221
2023
Q3 		$1.8M Buy
80,419
+11,966
+17% +$308K 0.05% 259
2023
Q2 		$1.74M Buy
68,453
+2,395
+4% +$58.1K 0.04% 289
2023
Q1 		$1.47M Buy
66,058
+8,804
+15% +$213K 0.04% 256
2022
Q4 		$1.36M Sell
57,254
-25,910
-31% -$602K 0.04% 252
2022
Q3 		$1.38M Sell
83,164
-31,194
-27% -$702K 0.05% 201
2022
Q2 		$2.28M Buy
114,358
+6,072
+6% +$123K 0.07% 152
2022
Q1 		$2.98M Buy
108,286
+13,328
+14% +$381K 0.06% 177
2021
Q4 		$3.91M Buy
94,958
+13,284
+16% +$587K 0.08% 155
2021
Q3 		$3.79M Sell
81,674
-31,353
-28% -$1.37M 0.1% 137
2021
Q2 		$4.52M Buy
113,027
+72,637
+180% +$3.11M 0.14% 104
2021
Q1 		$2.17M Buy
40,390
+19,481
+93% +$1.12M 0.08% 194
2020
Q4 		$1.02M Sell
20,909
-1,995
-9% -$92.4K 0.05% 222
2020
Q3 		$744K Buy
22,904
+7,892
+53% +$251K 0.04% 202
2020
Q2 		$389K Buy
15,012
+8,964
+148% +$223K 0.06% 247
2020
Q1 		$147K Buy
6,048
+3,113
+106% +$78.4K 0.08% 223
2019
Q4 		$82K Buy
+2,935
New +$76K 0.02% 226

Other funds holding VCYT

Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Pinnacle Associates
Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return
Brown Capital Management
Brown Capital Management Baltimore, Maryland $527M AUM 33.67% 1-Year Est. Return
Harbor Capital Advisors
Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Oppenheimer Asset Management
Oppenheimer Asset Management New York $9.5B AUM 23.46% 1-Year Est. Return
Louisiana State Employees Retirement System
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Concurrent Investment Advisors
Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return

Exchange Traded Concepts's VCYT Position: Q3 2026 in Review

Exchange Traded Concepts increased its Veracyte (VCYT) stake by 23% in Q3 2026, buying an estimated $1.62M and bringing the position to 177,873 shares worth $8.19M. The position accounts for 0.03% of the portfolio, ranked #405.

Exchange Traded Concepts first reported a position in VCYT in Q4 2019 and has held it in 28 quarters since. The position peaked at $8.47M in Q2 2026. 72 funds tracked by Wall St. Rank hold VCYT as of Q3 2026.

  • Exchange Traded Concepts held 177,873 shares of Veracyte worth $8.19M as of Q3 2026.
  • Exchange Traded Concepts bought 33,608 Veracyte shares in Q3 2026, an estimated $1.62M.
  • Veracyte made up 0.03% of Exchange Traded Concepts's portfolio in Q3 2026, its #405 holding.
  • Exchange Traded Concepts first reported a position in Veracyte in Q4 2019 and has held it in 28 quarters since.
  • Exchange Traded Concepts's Veracyte position peaked at $8.47M in Q2 2026.
  • 72 funds tracked by Wall St. Rank held Veracyte as of Q3 2026.

Based on Exchange Traded Concepts's 13F filing for Q3 2026, filed 28 Oct 2026.